J Postgrad Med Close
 

Figure 5: Indications for percutaneous transluminal renal angioplasty based upon various clinical presentations collectively labeled as "manifest RAS". *Revascularization is warranted only after adequate drug trial including renin angiotensin aldosterone system blockade

Figure 5: Indications for percutaneous transluminal renal angioplasty based upon various clinical presentations collectively labeled as